More capacity for temperature-sensitive cargo in Frankfurt imminent
Left to right: Jörg Bodenröder, Senior-Director of Handling Specials Products, Sören Stark, Lufthansa Cargo Board Member Operations, Karin Krestan, Head of Process & Operations Team and Mohammad Ali Seiraffi, Vice President of Handling Frankfurt.
Left to right: Jörg Bodenröder, Senior-Director of Handling Specials Products, Sören Stark, Lufthansa Cargo Board Member Operations, Karin Krestan, Head of Process & Operations Team and Mohammad Ali Seiraffi, Vice President of Handling Frankfurt.
Lufthansa Cargo has kicked off the development of the Cool Center at the Frankfurt hub. “We’ve gained a great deal of experience in the worldwide transport of sensitive medications. CEIV certification from IATA has recently highlighted this. The excellent collaboration with numerous shippers from the pharmaceutical and chemical industries has prompted demand for our service to grow consistently. We’re delighted to be able to offer our customers even more capacity and flexibility in our Cool Center as early as late summer“, said Board Member Operations Sören Stark, in the course of the ground-breaking ceremony. Following completion, as of late summer of this year, 8,000 square meters will be available for cool chain cargo. After the extension, the entire infrastructure of the Lufthansa Cargo Cool Center will be further improved. It was opened in December 2011 and currently offers 4,500 square meters in four different temperature-controlled chiller rooms (2 to 8°C, 15 to 25°C, -12 to -20°C and 5 to 15°C) as well as a deep-freeze room and direct access to the apron. As a result, it is currently the largest hub for temperature-sensitive freight in Europe. In late 2016 the IATA airline association awarded the CEIV seal of approvalfor pharmaceutical transport to Lufthansa Cargo and the Cool Center. Lufthansa Cargo improves the service continuously, taking into account the needs of the pharmaceutical industry as well as all the prerequisites from the EU GDP (Good Distribution Practice of Medicinal Products for Human Use).